Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension

E. Berra; M. Azizi; A. Capron; A. Hoieggen; F. Rabbia; S.E. Kjeldsen; J.A. Staessen; P. Wallemacq; A. Persu

doi:10.1161/HYPERTENSIONAHA.116.07464

Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension

E. Berra
, M. Azizi
, A. Capron
, A. Hoieggen
, F. Rabbia
, S.E. Kjeldsen
, J.A. Staessen
, P. Wallemacq
, A. Persu^*

^*Corresponding author for this work

Epidemiologie

Research output: Contribution to journal › (Systematic) Review article › peer-review

Original language	English
Pages (from-to)	297-306
Number of pages	10
Journal	Hypertension
Volume	68
Issue number	2
DOIs	https://doi.org/10.1161/HYPERTENSIONAHA.116.07464
Publication status	Published - 1 Aug 2016

Keywords

SEQUENTIAL NEPHRON BLOCKADE
SELF-REPORTED ADHERENCE
MEDICATION ADHERENCE
RENAL DENERVATION
THERAPEUTIC-EFFICACY
COST-EFFECTIVENESS
ANTIHYPERTENSIVE DRUGS
MASS-SPECTROMETRY
PHARMACOLOGICAL-PROPERTIES
PRESSURE

Access to Document

10.1161/HYPERTENSIONAHA.116.07464

Cite this

@article{4774ac13a3cb416ab257891993914b38,

title = "Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension",

keywords = "SEQUENTIAL NEPHRON BLOCKADE, SELF-REPORTED ADHERENCE, MEDICATION ADHERENCE, RENAL DENERVATION, THERAPEUTIC-EFFICACY, COST-EFFECTIVENESS, ANTIHYPERTENSIVE DRUGS, MASS-SPECTROMETRY, PHARMACOLOGICAL-PROPERTIES, PRESSURE",

author = "E. Berra and M. Azizi and A. Capron and A. Hoieggen and F. Rabbia and S.E. Kjeldsen and J.A. Staessen and P. Wallemacq and A. Persu",

year = "2016",

month = aug,

day = "1",

doi = "10.1161/HYPERTENSIONAHA.116.07464",

language = "English",

volume = "68",

pages = "297--306",

journal = "Hypertension",

issn = "0194-911X",

publisher = "Lippincott Williams \& Wilkins",

number = "2",

}

TY - JOUR

T1 - Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension

AU - Berra, E.

AU - Azizi, M.

AU - Capron, A.

AU - Hoieggen, A.

AU - Rabbia, F.

AU - Kjeldsen, S.E.

AU - Staessen, J.A.

AU - Wallemacq, P.

AU - Persu, A.

PY - 2016/8/1

Y1 - 2016/8/1

KW - SEQUENTIAL NEPHRON BLOCKADE

KW - SELF-REPORTED ADHERENCE

KW - MEDICATION ADHERENCE

KW - RENAL DENERVATION

KW - THERAPEUTIC-EFFICACY

KW - COST-EFFECTIVENESS

KW - ANTIHYPERTENSIVE DRUGS

KW - MASS-SPECTROMETRY

KW - PHARMACOLOGICAL-PROPERTIES

KW - PRESSURE

U2 - 10.1161/HYPERTENSIONAHA.116.07464

DO - 10.1161/HYPERTENSIONAHA.116.07464

M3 - (Systematic) Review article

SN - 0194-911X

VL - 68

SP - 297

EP - 306

JO - Hypertension

JF - Hypertension

IS - 2

ER -